- Release Date: 31/08/12 17:17
- Summary: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 11.78KB
FPH 31/08/2012 15:16 RELINT REL: 1516 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Directors and Officers Relevant Interests Name of director or officer of public issuer: Antony John CARTER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chairman B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) 299,952 ordinary Shares ii) 294,044 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Non Beneficial Name of registered holder of securities Fisher & Paykel Healthcare Employee Share Trustee Limited D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: "i) 29 August 2012 ii) 29 August 2012" Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the issue and transfer took place: "i) Director of Employee Share Purchase Trustee which transferred 299,952 ordinary shares to employees upon vesting. ii) Director of Employee Share Purchase Trustee company which issued 294,044 ordinary shares under a new plan." E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 29 August 2012 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) 299,952 ordinary shares ii) 294,044 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Non-Beneficial Ownership Name of registered holder of securities Fisher & Paykel Healthcare Employee Share Purchase Trustee Limited D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue & transfer "i) 29 August 2012 ii) 29 August 2012" Consideration received from issue & transfer "i) $NZNil ii) $NZNil" If the relevant interest was disposed of-- Date of disposal: N/A Consideration received from disposal: N/A Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the issue & transfer took place: "i) Director of Employee Share Purchase Trustee which transferred 299,952 ordinary shares to employees upon vesting. ii) Director of Employee Share Purchase Trustee company which issued 294,044 ordinary shares under a new plan." E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 16 December 2011 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 "i) 299,952 ordinary shares ii) 294,044 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Non-Beneficial Ownership Name of registered holder of securities 3 Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue: 4 "i) 29 August 2012 ii) 29 August 2012" Consideration paid for issue: 5 Nil If the relevant interest was disposed of-- Date of disposal: 6 N/A Consideration received from disposal: 7 N/A Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the issue and transfer took place: 8 "i) Director of Employee Share Purchase Trustee which transferred 299,952 ordinary shares to employees upon vesting. ii) Director of Employee Share Purchase Trustee company which issued 294,044 ordinary shares under a new plan." E Total number of transactions this notice relates to: 9 Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 11 July 2012 Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 "i) 896 ordinary shares ii) 1,549 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of transfer and issue: 4 "i) 29 August 2012 ii) 29 August 2012" Consideration paid for transfer and issue: 5 "i) NZ$Nil ii) NZ$2,338.99" If the relevant interest was disposed of-- Date of disposal: 6 Not applicable Consideration paid for disposal: 7 Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the transfer and issue took place: 8 "i) Transfer of 896 ordinary shares upon vesting under an employee share scheme ii) New issue of 1,549 shares under an employee share scheme" E Total number of transactions this notice relates to: 9 Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 16 December 2011 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Research & Development B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 "i) 869 ordinary shares ii) 1,549 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of transfer and issue: 4 "i) 29 August 2012 ii) 29 August 2012" Consideration paid for transfer and issue: 5 "i) NZ$Nil ii) NZ$2,338.99" If the relevant interest was disposed of-- Date of disposal: 6 Not Applicable Consideration paid for disposal: 7 Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the transfer and issue took place: 8 "i) Transfer of 896 ordinary shares upon vesting under an employee share scheme ii) New issue of 1,549 shares under an employee share scheme" E Total number of transactions this notice relates to: 9 Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 16 December 2011 Name of director or officer of public issuer: Michael Robert BATTY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Group Operations Manager B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 "896 ordinary shares " C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial interest Name of registered holder of securities 3 Michael Robert BATTY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue: 4 " 29 August 2012 " Consideration paid for issue: 5 "NZ$Nil " If the relevant interest was disposed of-- Date of disposal: 6 Not Applicable Consideration paid for disposal: 7 Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, issue took place: 8 "Transfer of 896 ordinary shares upon vesting under an employee share scheme " E Total number of transactions this notice relates to: 9 One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 26 June 2012 Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 "i) 869 ordinary shares ii) 1,549 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of transfer and issue 4 "i) 29 August 2012 ii) 29 August 2012" Consideration paid for transfer and issue: 5 "i) NZ$Nil ii) NZ$2,338.99" If the relevant interest was disposed of-- Date of disposal: 6 N/A Consideration received from disposal: 7 N/A Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the trasfer and issue took place: 8 "i) Transfer of 896 ordinary shares upon vesting under an employee share scheme ii) New issue of 1,549 shares under an employee share scheme" E Total number of transactions this notice relates to: 9 Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 16 December 2011 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 "i) 299,952 ordinary shares ii) 294,044 ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Non-Beneficial Ownership Name of registered holder of securities 3 Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue: 4 "i) 29 August 2012 ii) 29 August 2012" Consideration paid for issue: 5 Nil If the relevant interest was disposed of-- Date of disposal: 6 N/A Consideration received from disposal: 7 N/A Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the issue and transfer took place: 8 "i) Director of Employee Share Purchase Trustee which transferred 299,952 ordinary shares to employees upon vesting. ii) Director of Employee Share Purchase Trustee company which issued 294,044 ordinary shares under a new plan." E Total number of transactions this notice relates to: 9 Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 11 July 2012 End CA:00226767 For:FPH Type:RELINT Time:2012-08-31 15:17:00
Ann: RELINT: FPH: Disclosure of Directors and Off
Add to My Watchlist
What is My Watchlist?
